Open AccessReporting Cases of Telogen Effluvium as a sequelae of COVID‐19 Infection
Author(s) -
Shafia Mushtaq Allaqaband,
Farooq Naqashbandi
Publication year - 2022
Publication title -
journal of drug delivery and therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2250-1177
DOI - 10.22270/jddt.v12i1.5309
Subject(s) - covid-19 , medicine , dermatology , disease , infectious disease (medical specialty)
Objective: to report cases of Telogen effluvium (T.E) as a sequele of COVID 19
Material and methods: Ten patients were reported between May and august 2021with median age group of 21years. There were five males and five females in the study. All the cases were diagnosed with positive RTPCR when they had COVID and recovered fully without need for hospitalization. T.E occurred in our group after median of two months (range 1-2months) following COVID 19 infection. Detailed medical history of all the patients was taken.
Results: all the ten cases showed early onset of T.E within three months of infection.
Keywords: Telogen Effluvium, Covid 19, RTPCR